|
No.
|
Drug Name
|
Decision
|
|
1)
|
Amoxycillin 1000mg Tablet
(Ospamox)
|
Agreed to restore as Special Formulary.
Pharmacy to monitor one year usage.
|
|
2)
|
Dabigatran 110mg Capsule
(Pradaxa)
|
Agreed to add Neurologist as prescriber.
|
|
3)
|
Dabigatran 150mg Capsule
(Pradaxa)
|
Agreed to add Neurologist as prescriber.
|
|
4)
|
Dabigatran 75mg Capsule
(Pradaxa)
|
Agreed to add Neurologist as prescriber.
|
|
5)
|
Dulaglutide 1.5mg Injection
(Trulicity)
|
Agreed to accept Dulaglutide 1.5mg Injection
(Trulicity) as Special Formulary.
Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.
|
|
6)
|
EDTA 2% Eye Drops
|
Agreed to accept as Standard Formulary.
|
|
7)
|
Flecainide 100mg Tablet
(Tambocor)
|
Agreed to accept as Special Formulary.
|
|
8)
|
Insulin Degludec 70% Aspart 30% 300units/3mL Pen Injection
(Ryzodeg FlexTouch)
|
Rejected as Special Formulary.
Costs more than existing agents available in the UMMC's Formulary.
Available in UMSC for purchase and slow moving in UMSC.
|
|
9)
|
Levamisole 50mg Tablet
|
Agreed to accept as Standard Formulary.
|
|
10)
|
Mirabegron 25mg Prolonged-Release Tablet
(Betmiga)
|
Rejected as Standard Formulary, to maintain current status as Special Formulary.
|
|
11)
|
Mirabegron 50mg Prolonged-Release Tablet
(Betmiga)
|
Rejected as Standard Formulary, to maintain current status as Special Formulary.
|
|
12)
|
Quadrivalent Influenza Vaccine Injection, Split Virion, Inactivated
(VaxigripTetra)
|
Rejected to add Infectious Disease Specialist as prescriber, to maintain current restriction.
However, D&T Committee to propose to higher management for free annual vaccination for UMMC front liners as per Ministry of Health's indication.
|
|
13)
|
Saccharomyces boulardii CNCM I-745 250mg Capsule
(Bioflor)
|
Agreed to accept as Special Formulary in PharmSelatan.
Non-claimable.
|
|
14)
|
Saccharomyces boulardii CNCM I-745 250mg Powder for Oral Suspension
(Bioflor)
|
Agreed to accept as Special Formulary in PharmSelatan.
Non-claimable.
|
|
15)
|
Zonisamide 100mg Tablet
(Zonegran)
|
To invite Neurologist to the next D&T Meeting.
Suggest to remove one item to replace Zonisamide in Standard Formulary.
|
|
16)
|
Exenatide 2mg Injection
(Bydureon)
|
Agreed to delete Exenatide 2mg Injection (Bydureon) from the UMMC's formulary.
Reason: Accepted Dulaglutide 1.5mg Injection (Trulicity) as Special Formulary in D&T Bil. 03/2019.
|
|
17)
|
Propafenone 150mg Tablet
(Rytmonorm)
|
Agreed to delete from the UMMC's formulary.
Company discontinued distribution.
|
|
18)
|
Human Albumin 20% Injection Guideline
|
Agreed to accept proposed guideline.
|
|
19)
|
New Drug Request Form / SOP Modification
|
Agreed to proceed to propose to higher management for approval.
|
